首页> 外文期刊>Clinical infectious diseases >First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan.
【24h】

First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan.

机译:日本首例新德里产金属β-内酰胺酶1的大肠杆菌感染病例。

获取原文
获取原文并翻译 | 示例
           

摘要

To the Editor-Emergence of multi-drug-resistant organisms is a threat to public health, because there is limited effort devoted to the development of new antibiotics [1]. Multiple new mechanisms of resistance have been described recently, including a new type of carbapenem resistance gene, la_NDM_1 reported in 2009 [2]. Infections due to strains with bla_NDM_1 have been reported in India, Pakistan, the United Kingdom, and the United States [2-4].We report the first case, to our knowledge, of New Delhi metallo-beta lactamase 1 (NDM-l)-producing Es-cherichia coli infection in Japan. A 54-year-old Japanese man traveled to India for business in March 2009. During his trip, he developed dysarthria, blurring of his left eye, and tingling in his right upper extremity.
机译:对编者来说,多重耐药性生物的出现对公共健康构成了威胁,因为致力于开发新抗生素的努力有限[1]。最近已经描述了多种新的耐药机制,包括2009年报道的新型碳青霉烯耐药基因la_NDM_1 [2]。在印度,巴基斯坦,英国和美国已经报道了由bla_NDM_1菌株引起的感染[2-4]。据我们所知,第一例是新德里金属β-内酰胺酶1(NDM-1 )在日本生产大肠杆菌。一名54岁的日本男子于2009年3月前往印度经商。在旅途中,他患了构音障碍,左眼模糊,右上肢发麻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号